| 英文摘要 |
Smoking is a major risk factor for cardiovascular disease and various chronic conditions; for patients with myocardial infarction (MI), smoking cessation is especially critical in determining long-term prognosis. Research indicates that patients who successfully quit smoking shortly after an MI can reduce their ten-year mortality risk by approximately 50%, underscoring the importance of smoking cessation as a secondary prevention strategy. While current behavioral and pharmacological interventions for smoking cessation have demonstrated short-term efficacy, long-term abstinence rates remain suboptimal, indicating that further improvement in prognostic outcomes is still needed. One key challenge lies in limited patient involvement in smoking cessation treatment decision-making, resulting in insufficient treatment adherence and intrinsic motivation. Shared Decision Making (SDM) emphasizes patient autonomy and active participation, and in recent years has demonstrated promise in smoking cessation interventions across adolescents and adult populations. By fostering active patient participation in treatment decision-making, SDM may enhance treatment adherence and sustained smoking abstinence, thereby improving long-term cardiovascular outcomes. For smokers who have experienced major cardiovascular events, hospitalization represents a critical window of opportunity for behavior change. Using SDM to develop an integrated intervention plan during hospitalization can thus be expected to increase smoking cessation success rates and promote long-term health benefits. Reviewing evidence-based guidelines for post-MI smoking cessation, exploring clinical intervention strategies and associated factors, and evaluating the potential role of SDM in smoking cessation treatment, this article aims to provide a practical, evidence-informed intervention model to facilitate clinical implementation and further research. |